Woodline Partners LP Jazz Pharmaceuticals PLC Transaction History
Woodline Partners LP
- $11 Billion
- Q3 2024
A detailed history of Woodline Partners LP transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Woodline Partners LP holds 279,208 shares of JAZZ stock, worth $34.5 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
279,208
Previous 2,589
10684.4%
Holding current value
$34.5 Million
Previous $276,000
11175.36%
% of portfolio
0.28%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding JAZZ
# of Institutions
512Shares Held
57.5MCall Options Held
188KPut Options Held
133K-
Black Rock Inc. New York, NY6.15MShares$760 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$756 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.49MShares$309 Million0.6% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.1MShares$260 Million0.56% of portfolio
-
State Street Corp Boston, MA1.95MShares$241 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.76B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...